Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Multiple bacterial enzymes and cell wall components" refers to a diverse group of proteins and polymers that mediate the synthesis, remodeling, and structural integrity of the bacterial cell wall. The bacterial cell wall is principally made of peptidoglycan—a polymer of sugars (N-acetylglucosamine and N-acetylmuramic acid) and peptides—supplemented by teichoic acids in Gram-positive bacteria and by an outer membrane containing lipopolysaccharide in Gram-negative bacteria[2][4][8]. Enzymes targeted include various peptidoglycan biosynthesis proteins (MurA–MurF, MurG, penicillin-binding proteins), peptidoglycan hydrolases, and enzymes modifying teichoic acid and lipoproteins[3][4][9]. These targets are vital for bacterial viability, cell shape, division, and pathogenicity, and are major points of vulnerability for antibiotics such as beta-lactams and glycopeptides[1][3][5]. The broadness of this designation indicates a composite, not a precise target, and is too vague for direct use as a therapeutic target name. If needed, to extract information about specific enzymes or cell wall components (e.g., "penicillin-binding protein 2", "MurA", "lipopolysaccharide", etc.), each would require its own entry with a precise canonical name and details.
Inhibition of peptidoglycan cross-linking (e.g., inhibition of penicillin-binding proteins by beta-lactams)[3][5][8] - Inhibition of glycan strand polymerization - Disruption/degradation of cell wall by exogenous enzymes (e.g., endolysins)[1][9] - Inhibition of specific biosynthetic enzymes (e.g., MurA–MurF, Alr, Ddl, MraY, MurG)[3] - Disruption of cell membrane associated with cell wall (e.g., by polymyxins)
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple bacterial enzymes and cell wall components.